ZTALMY
NDC 81583-100, ganaxolone, suspension, from Immedica Pharma US Inc.
- Product NDC
- 81583-100
- Status
- Listed
- Labeler
- Immedica Pharma US Inc
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215904
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/81583-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GANAXOLONE50 mg/mL
Pharmacologic classes
GABA A Receptor Positive Modulators [MoA]; Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81583-100-01 | 81583010001 | 1 BOTTLE, PLASTIC in 1 CARTON (81583-100-01) / 110 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d91612c4-b03a-4be4-a1ee-6a13e3b83d4e
Use it
Look up 81583-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81583-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81583-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.